New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles


Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

Injectable Skin Lightening Products: What You Should Know


Wed, 02 Sep 2015 07:00:00 -0400

Injectable skin lightening products are unapproved, untested drugs that could potentially cause harm, FDA warns. FDA has not approved any injectable drugs for skin whitening or lightening.

FDA's MedWatch Safety Alerts for Consumers: July 2015


Tue, 25 Aug 2015 07:00:00 -0400

FDA is warning consumers about children's cough-and-cold medicine with codeine, the risks of nonsteroidal anti-inflammatory drugs (NSAIDs), unapproved prescription ear products and drugs from Moses Lake Professional Pharmacy.

Healthy Breakfasts for Kids: It's All about Balance


Thu, 13 Aug 2015 08:00:00 -0400

Healthy breakfasts are a must for kids. Here are seven easy tips for making that happen.

Vaccines: FDA Guide Tells You What You Need to Know


Tue, 11 Aug 2015 08:25:00 -0400

Describes different types of vaccines for children and answers parent questions.

Dealing with ADHD: What You Need to Know


Thu, 06 Aug 2015 08:45:00 -0400

How to recognize and treat ADHD.


Food and Drug Administration--Press Releases

http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.xml

FDA approves new drug treatment for nausea and vomiting from chemotherapy


Wed, 02 Sep 2015 09:38:00 -0400

The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in combination with other drugs (antiemetic agents) that prevent nausea and vomiting associated with initial and repeat courses of vomit-inducing (emetogenic and highly emetogenic) cancer chemotherapy.

FDA approves Repatha to treat certain patients with high cholesterol


Thu, 27 Aug 2015 17:10:00 -0400

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

FDA takes action against three tobacco manufacturers for making “additive-free” and/or “natural” claims on cigarette labeling


Thu, 27 Aug 2015 10:30:00 -0400

Today the U.S. Food and Drug Administration issued warning letters to three tobacco manufacturers — ITG Brands LLC, Santa Fe Natural Tobacco Company Inc., and Sherman’s 1400 Broadway N.Y.C. Ltd. — who describe their cigarettes on product labeling as “additive-free” and/or “natural.” The warning letters are for violations of section 911 of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

FDA extends use of Promacta in young children with rare blood disorder


Mon, 24 Aug 2015 10:43:00 -0400

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.

FDA approves first treatment for sexual desire disorder


Tue, 18 Aug 2015 18:42:00 -0400

The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to Addyi’s approval, there were no FDA-approved treatments for sexual desire disorders in men or women.




nnn